Viewing Study NCT03554434


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-26 @ 1:06 AM
Study NCT ID: NCT03554434
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2020-03-02
First Post: 2018-05-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Expanded Access Program for AM0010 (Pegilodecakin)
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module